Our client has developed a novel production method for drug manufacturing that enables a scalable, decentralized, and flexible way of production. To operationalize this strategy and launch the new production method, the client requires a strong automation and digitalization approach. In addition, the client requires support in defining the roll-out and go-to-market (G2M) strategy for its innovation.

Our team of industry and technology experts has developed a holistic automation and digitalization approach to enable the operationalization of the new innovative production method. One key element was the definition and development of a tailor-made performance digital twin to enable remote monitoring of the production cell. Beyond the technical enablement, our team also developed the strategy for roll-out at different sites, including hiring and training requirements.

Enabled a novel manufacturing approach to be market-ready within their respective time frame.